Literature DB >> 23457265

Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth.

Bettina Schmid1, Alexander Hruscha, Sebastian Hogl, Julia Banzhaf-Strathmann, Katrin Strecker, Julie van der Zee, Mathias Teucke, Stefan Eimer, Jan Hegermann, Maike Kittelmann, Elisabeth Kremmer, Marc Cruts, Barbara Solchenberger, Laura Hasenkamp, Frauke van Bebber, Christine Van Broeckhoven, Dieter Edbauer, Stefan F Lichtenthaler, Christian Haass.   

Abstract

Mutations in the Tar DNA binding protein of 43 kDa (TDP-43; TARDBP) are associated with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43(+) inclusions (FTLD-TDP). To determine the physiological function of TDP-43, we knocked out zebrafish Tardbp and its paralogue Tardbp (TAR DNA binding protein-like), which lacks the glycine-rich domain where ALS- and FTLD-TDP-associated mutations cluster. tardbp mutants show no phenotype, a result of compensation by a unique splice variant of tardbpl that additionally contains a C-terminal elongation highly homologous to the glycine-rich domain of tardbp. Double-homozygous mutants of tardbp and tardbpl show muscle degeneration, strongly reduced blood circulation, mispatterning of vessels, impaired spinal motor neuron axon outgrowth, and early death. In double mutants the muscle-specific actin binding protein Filamin Ca is up-regulated. Strikingly, Filamin C is similarly increased in the frontal cortex of FTLD-TDP patients, suggesting aberrant expression in smooth muscle cells and TDP-43 loss-of-function as one underlying disease mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23457265      PMCID: PMC3612625          DOI: 10.1073/pnas.1218311110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  The many faces of filamin: a versatile molecular scaffold for cell motility and signalling.

Authors:  Yuanyi Feng; Christopher A Walsh
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

2.  Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.

Authors:  Lien-Szu Wu; Wei-Cheng Cheng; C-K James Shen
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

3.  Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro.

Authors:  Misato Fujita; Hiroaki Mitsuhashi; Sumio Isogai; Takahiro Nakata; Atsushi Kawakami; Ikuya Nonaka; Satoru Noguchi; Yukiko K Hayashi; Ichizo Nishino; Akira Kudo
Journal:  Dev Biol       Date:  2011-10-14       Impact factor: 3.582

4.  TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes.

Authors:  Yukio Kawahara; Ai Mieda-Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-09       Impact factor: 11.205

5.  RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS.

Authors:  Shangxi Xiao; Teresa Sanelli; Samar Dib; David Sheps; Joseph Findlater; Juan Bilbao; Julia Keith; Lorne Zinman; Ekaterina Rogaeva; Janice Robertson
Journal:  Mol Cell Neurosci       Date:  2011-03-21       Impact factor: 4.314

6.  Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.

Authors:  Edor Kabashi; Li Lin; Miranda L Tradewell; Patrick A Dion; Valérie Bercier; Patrick Bourgouin; Daniel Rochefort; Samar Bel Hadj; Heather D Durham; Christine Vande Velde; Guy A Rouleau; Pierre Drapeau
Journal:  Hum Mol Genet       Date:  2009-12-03       Impact factor: 6.150

7.  Cerebral blood flow and oxygen metabolism in progressive dementia associated with amyotrophic lateral sclerosis.

Authors:  M Tanaka; S Kondo; S Hirai; X Sun; T Yamagishi; K Okamoto
Journal:  J Neurol Sci       Date:  1993-12-01       Impact factor: 3.181

8.  TDP-43 is a developmentally regulated protein essential for early embryonic development.

Authors:  Chantelle F Sephton; Shannon K Good; Stan Atkin; Colleen M Dewey; Paul Mayer; Joachim Herz; Gang Yu
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

9.  Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy.

Authors:  Rachael M Duff; Valerie Tay; Peter Hackman; Gianina Ravenscroft; Catriona McLean; Paul Kennedy; Alina Steinbach; Wiebke Schöffler; Peter F M van der Ven; Dieter O Fürst; Jaeguen Song; Kristina Djinović-Carugo; Sini Penttilä; Olayinka Raheem; Katrina Reardon; Alessandro Malandrini; Simona Gambelli; Marcello Villanova; Kristen J Nowak; David R Williams; John E Landers; Robert H Brown; Bjarne Udd; Nigel G Laing
Journal:  Am J Hum Genet       Date:  2011-05-27       Impact factor: 11.025

10.  Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo.

Authors:  Andrea D'Ambrogio; Emanuele Buratti; Cristiana Stuani; Corrado Guarnaccia; Maurizio Romano; Youhna M Ayala; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

View more
  53 in total

1.  TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.

Authors:  Jonathan P Ling; Olga Pletnikova; Juan C Troncoso; Philip C Wong
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

Review 2.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

3.  Between new genetic discoveries and large randomized trials--neurological research in the era of systems medicine.

Authors:  Thomas Misgeld; Stefan F Lichtenthaler; Martin Dichgans
Journal:  EMBO Rep       Date:  2013-05-14       Impact factor: 8.807

4.  Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis.

Authors:  Chunxing Yang; Hongyan Wang; Tao Qiao; Bin Yang; Leonardo Aliaga; Linghua Qiu; Weijia Tan; Johnny Salameh; Diane M McKenna-Yasek; Thomas Smith; Lingtao Peng; Melissa J Moore; Robert H Brown; Huaibin Cai; Zuoshang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

5.  Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function.

Authors:  Wen Li; Ashley N Reeb; Binyan Lin; Praveen Subramanian; Erin E Fey; Catherine R Knoverek; Rachel L French; Eileen H Bigio; Yuna M Ayala
Journal:  J Biol Chem       Date:  2017-02-06       Impact factor: 5.157

Review 6.  TDP-43 in the spectrum of MND-FTLD pathologies.

Authors:  Lanier Heyburn; Charbel E-H Moussa
Journal:  Mol Cell Neurosci       Date:  2017-07-04       Impact factor: 4.314

7.  Splicing repression is a major function of TDP-43 in motor neurons.

Authors:  Aneesh Donde; Mingkuan Sun; Jonathan P Ling; Kerstin E Braunstein; Bo Pang; Xinrui Wen; Xueying Cheng; Liam Chen; Philip C Wong
Journal:  Acta Neuropathol       Date:  2019-07-22       Impact factor: 17.088

Review 8.  TDP43 and RNA instability in amyotrophic lateral sclerosis.

Authors:  Kaitlin Weskamp; Sami J Barmada
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

9.  Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.

Authors:  Ruth Eichner; Michael Heider; Vanesa Fernández-Sáiz; Frauke van Bebber; Anne-Kathrin Garz; Simone Lemeer; Martina Rudelius; Bianca-Sabrina Targosz; Laura Jacobs; Anna-Maria Knorn; Jolanta Slawska; Uwe Platzbecker; Ulrich Germing; Christian Langer; Stefan Knop; Herrmann Einsele; Christian Peschel; Christian Haass; Ulrich Keller; Bettina Schmid; Katharina S Götze; Bernhard Kuster; Florian Bassermann
Journal:  Nat Med       Date:  2016-06-13       Impact factor: 53.440

10.  Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.

Authors:  Kaitlin Weskamp; Elizabeth M Tank; Roberto Miguez; Jonathon P McBride; Nicolás B Gómez; Matthew White; Ziqiang Lin; Carmen Moreno Gonzalez; Andrea Serio; Jemeen Sreedharan; Sami J Barmada
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.